⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38344 | 0.90 | — | — | |
| SCHEMBL5082130 | 0.90 | — | — | |
| SCHEMBL2223360 | 0.88 | — | — | |
| SCHEMBL8785550 | 0.88 | — | — | |
| SCHEMBL318964 | 0.78 | — | — | |
| SCHEMBL6999245 | 0.69 | — | — | |
| SCHEMBL61344 | 0.69 | — | — | |
| SCHEMBL10226234 | 0.65 | — | — | |
| SCHEMBL272115 | 0.64 | — | — | |
| SCHEMBL3392366 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3180 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399209-A1 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH (DE) | 2024-07-17 | — | — | EP | claimed |
| US-12030903-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2024-07-09 | — | — | US | claimed |
| CN-118290322-A | Aromatic molecules for the treatment of pathological conditions | 赛尼欧普罗有限责任公司 | 2024-07-05 | — | — | CN | claimed |
| CN-115109036-B | Quinazoline compound, composition and application thereof | 北京赛特明强医药科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-20240165116-A1 | ROCK2 INHIBITOR FOR THE TREATMENT OF VIRAL INFECTION | GRAVITON BIOSCIENCE BV (NL) | 2024-05-23 | — | — | US | claimed |
| US-20240140895-A1 | NOVEL AROMATIC MOLECULES | Xeniopro GmbH (DE) | 2024-05-02 | — | — | US | claimed |
| CN-117957223-A | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-115894455-B | Quinazoline compound, composition and application thereof | 北京赛特明强医药科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| US-20240101553-A1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | claimed |
| CN-115894486-B | Hydrogenated pyridoquinazoline compound, composition and application thereof | 北京赛特明强医药科技有限公司 | 2024-02-09 | — | — | CN | claimed |
| EP-0218689-A1 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES AND COMPOSITIONS. | UPJOHN CO (US) | 1987-04-22 | — | — | EP | claimed |
| EP-0214158-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1987-03-18 | — | — | EP | claimed |
| WO-1986005982-A2 | ANTHELMINTIC QUINOLINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | UPJOHN CO (US) | 1986-10-23 | — | — | WO | claimed |
| WO-1986004582-A1 | ANTHELMINTIC PYRIDINYL ACYLHYDRAZONES, METHOD OF USE AND COMPOSITIONS | THE UPJOHN COMPANY (US) | 1986-08-14 | — | — | WO | claimed |
| EP-0081719-B1 | 2-NITRO-IMIDAZOLS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1986-04-23 | — | — | EP | claimed |
| US-4562256-A | HYPOTENSIVE AGENTS | SHIONOGI & CO., LTD. (JP) | 1985-12-31 | — | — | US | claimed |
| US-4515790-A | Antiprotozoal 2-nitroimidazole compounds | HOFFMANN-LA ROCHE INC. (US) | 1985-05-07 | — | — | US | claimed |
| US-4428935-A | BETA-LACTAMASE INHIBITORS | PFIZER INC. (US) | 1984-01-31 | — | — | US | claimed |
| EP-0081719-A2 | 2-Nitro-imidazols | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-06-22 | — | — | EP | claimed |
| EP-0000106-B1 | 2-ALKYL NICOTINOIDS AND PROCESSES FOR THEIR PRODUCTION AND USE | PHILIP MORRIS INCORPORATED (US) | 1982-02-17 | — | — | EP | claimed |